368 reports of this reaction
2.3% of all MESNA INJECTION reports
#6 most reported adverse reaction
ANAEMIA is the #6 most commonly reported adverse reaction for MESNA INJECTION, manufactured by Gland Pharma Limited. There are 368 FDA adverse event reports linking MESNA INJECTION to ANAEMIA. This represents approximately 2.3% of all 16,183 adverse event reports for this drug.
Patients taking MESNA INJECTION who experience anaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAEMIA is a less commonly reported adverse event for MESNA INJECTION, but still significant enough to appear in the safety profile.
In addition to anaemia, the following adverse reactions have been reported for MESNA INJECTION:
The following drugs have also been linked to anaemia in FDA adverse event reports:
ANAEMIA has been reported as an adverse event in 368 FDA reports for MESNA INJECTION. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAEMIA accounts for approximately 2.3% of all adverse event reports for MESNA INJECTION, making it a notable side effect.
If you experience anaemia while taking MESNA INJECTION, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.